Viewing Study NCT00121212



Ignite Creation Date: 2024-05-05 @ 11:45 AM
Last Modification Date: 2024-10-26 @ 9:12 AM
Study NCT ID: NCT00121212
Status: COMPLETED
Last Update Posted: 2015-10-30
First Post: 2005-07-19

Brief Title: Positron Emission Tomography in Prostate Cancer
Sponsor: Washington University School of Medicine
Organization: Washington University School of Medicine

Study Overview

Official Title: Positron Emission Tomography in Prostate Cancer
Status: COMPLETED
Status Verified Date: 2015-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: RATIONALE Diagnostic procedures such as positron emission tomography using carbon-11 acetate may help find metastases from prostate cancer and may help predict whether prostate cancer will come back after treatment

PURPOSE This clinical trial is studying how well positron emission tomography using carbon-11 acetate works in finding metastases and predicting recurrence in patients with prostate cancer who are at risk for recurrence after treatment
Detailed Description: The overall goal of this project is determination of the role of PET in patients with newly diagnosed medium- and high-risk prostate cancer in whom the standard clinical and imaging workup is negative Thus the incremental value of PET will be determined in this important group

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
R01CA101734 NIH None None
P30CA091842 NIH None None
WU-03-0315 US NIH GrantContract None httpsreporternihgovquickSearchP30CA091842